1 (626) 351-3700

MariaDB SkySQL Wins 2023 DEVIES Award for Data Storage & Management

Recognized for outstanding design, engineering and innovation in developer technology REDWOOD CITY, Calif., and DUBLIN – February 16, 2023 – MariaDB plc (NYSE: MRDB), a new generation cloud database company, announced that its fully managed cloud database service SkySQL has won the prestigious 2023 DEVIES Award for Data Storage & Management. MariaDB accepted the DEVIES Awards, the...

Read More >

MariaDB Receives STIG Approval

REDWOOD CITY, Calif. and HELSINKI – August 26, 2022 – MariaDB® Corporation today announced that the Defense Information Systems Agency (DISA), a U.S. Department of Defense (DOD) combat support agency, has approved the Security Technical Implementation Guide (STIG) for MariaDB Enterprise Server. To approve the STIG, DISA evaluated MariaDB Enterprise Server against hundreds of DOD security...

Read More >

MariaDB Looks To Boost Geospatial Data Capabilities With Acquisition

Database and database-as-a-service provider MariaDB has acquired a developer of advanced geospatial technology in a move that will make it easier for developers to incorporate geospatial data into their applications. MariaDB’s acquisition of CubeWerx comes as the volume of geospatial data is exploding, including location-based and imagery data generated by...

Read More >

MariaDB SkySQL Continues to Gain Industry Recognition

REDWOOD CITY, Calif. and HELSINKI – March 29, 2022 – MariaDB® Corporation today announced that MariaDB has received recognition as “Database of the Year” in the LinuxQuestions.org Members Choice Awards poll. This marks the ninth consecutive year MariaDB has earned this recognition. Additionally, MariaDB has been named a finalist for...

Read More >

AIVITA Biomedical Announces 96% Immune Response Against SARS-CoV-2 in Phase 2 Clinical Trial of a Personalized Vaccine

IRVINE, Calif., Sept. 13, 2021 /PRNewswire/ — AIVITA Biomedical, Inc., a private biotechnology company specializing in innovative cell therapies, today announced results from its Phase 2 clinical study testing AIVITA’s anti-SARS-CoV-2 Vaccine Enabling Kit, which allows any minimally-equipped facility to make personalized COVID-19 vaccines during the course of 2 patient visits...

Read More >

AIVITA Biomedical’s Phase 2 Glioblastoma Trial Shows Improved Progression Free Survival

Personalized cancer vaccine increases progression-free survival (PFS) by 50% IRVINE, Calif., June 8, 2021 /PRNewswire/ — AIVITA Biomedical, Inc., a private biotechnology company specializing in innovative stem cell applications, today announced data from its multi-center Phase 2 clinical trial of its personalized cancer vaccine, AV-GBM-1, in patients with newly diagnosed glioblastoma...

Read More >

Randomized Clinical Trial Results Confirm PleuraFlow Reduces Take Back for Bleeding in Cardiac Surgery Patients

RVINE, Calif.–(BUSINESS WIRE)–ClearFlow, Inc., a medical device company based in Irvine, California, has announced positive clinical trial results published in the peer-reviewed Journal of Cardiothoracic Surgery. The findings are reported by cardiac surgeons at the Montreal Heart Institute, in Montreal, Quebec, Canada in the article, “Active clearance vs conventional management of chest...

Read More >

FanGraphs Baseball Hits a Home Run with MariaDB SkySQL and SkyDBA

SkySQL on GCP powers FanGraphs’ comprehensive, data-driven projections for major and minor league baseball   REDWOOD CITY, Calif. and HELSINKI – March 25, 2021 – MariaDB® Corporation today announced that popular baseball analysis site FanGraphs has drafted MariaDB SkySQL as its cloud database running on Google Cloud Platform (GCP) and...

Read More >

MariaDB SkySQL Awarded Two Major 2021 Industry Honors

REDWOOD CITY, Calif. and HELSINKI – March 10, 2021 – MariaDB® Corporation today announced that its cloud database MariaDB SkySQL has won the InfoWorld Technology of the Year Awards for 2021. The awards, which identify the best and most innovative products on the IT landscape, recognized SkySQL for its ability...

Read More >
Scroll to Top